Q: My cousin was diagnosed with dystonia, what is this? A: Dystonia is a disorder of involuntary muscle contractions that may cause repetitive and/or abnormal movement or postures, for example ...

Transcranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized patients with ...

MICKLETON, N.J. (WPVI) -- Nearly everyone gets a muscle cramp from time to time. When muscle contractions won't stop and can't be controlled, that's called dystonia. A South Jersey man is now sharing ...

Adrian is the first paediatric patient with GNAO1 in Asia to undergo Deep Brain Stimulation surgery for this condition. SINGAPORE – Fewer than 500 people worldwide are known to have a rare genetic ...

Athetosis and chorea are two types of involuntary movements that can occur in children and adults with neurological conditions, such as cerebral palsy. The movements have different features, and the ...

Deep brain stimulation is a surgical brain therapy used to treat symptoms of movement disorders such as dystonia, Parkinson’s disease and epilepsy. Performing over 100 DBS procedures annually, the ...

Dyskinesia is a state in which someone experiences involuntary movements. Chorea is a type of dyskinesia. Other types of dyskinesia include tics, myoclonus, dystonia, and akathisia. There are ...

The case description for a Case Records of the Massachusetts General Hospital appears below. What is the diagnosis? Cast your vote. The correct diagnosis, along with the full description of the case ...

Our one-year pediatric movement disorders fellowship is designed to prepare child neurologists to become experts in the evaluation and treatment of conditions causing unwanted involuntary movements.

Kristin Weiland is a documentary film producer and writer with a background in crisis management and ethnographic research. She specializes in investigative and social impact documentary projects, and ...

Neurocrine Biosciences said on Monday its drug failed to meet the main goal in a late-stage clinical trial in patients with a type of disorder that disrupts the brain's ability to control muscles.